(1)
Long-Term Safety and Efficacy of Belzutifan in Von Hippel–Lindau Syndrome: A VHL Coordinating Care Center Experience. jkcvhl 2025, 12 (3), 25-31. https://doi.org/10.15586/jkcvhl.v12i3.425.